普通球囊与药物洗脱球囊血管成形术治疗透析动静脉瘘近吻合口狭窄的系统综述与荟萃分析
该系统综述与荟萃分析比较了不同腔内技术治疗动静脉瘘近吻合口狭窄的效果,共纳入3项随机试验和3项观察性研究。荟萃分析显示,药物洗脱球囊(DEB)血管成形术在术后12个月的主要辅助通畅率显著优于普通球囊(PTA),但6个月时两组无显著差异,结论需更高质量数据验证。
要点
- DEB血管成形术治疗近吻合口AVF狭窄的12个月主要辅助通畅率显著优于PTA。
- 6个月主要辅助通畅率在DEB与PTA间无统计学显著差异。
- DEB可能提供更长期通畅,但需进一步高质量研究确认。
核心结论
- DEB血管成形术治疗近吻合口AVF狭窄可能比PTA更有效,但需更高质量数据确认。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南,检索MEDLINE、Embase和Cochrane Central Register of Controlled Trials数据库至2018年6月12日。
- 共纳入3项随机试验和3项观察性研究;其中3项研究(342例患者)定性分析高压球囊、常规PTA和支架,3项研究(141例患者)纳入DEB与PTA的荟萃分析。
主要发现
- DEB血管成形术在术后12个月的主要辅助通畅率显著高于PTA(OR 3.66,95%CI 1.32-10.14,I2=49%)。
- 6个月主要辅助通畅率在DEB与PTA间无统计学显著差异(OR 2.03,95%CI 0.64-6.45,I2=50%)。
- DEB组72例AVF中58例在6个月时保持通畅,PTA组69例中45例保持通畅;12个月时DEB组72例中48例保持通畅,PTA组69例中23例保持通畅。
关键数值与推荐
- 12个月主要辅助通畅率:DEB vs PTA的OR为3.66(95%CI 1.32-10.14,I2=49%)。
- 6个月主要辅助通畅率:DEB vs PTA的OR为2.03(95%CI 0.64-6.45,I2=50%)。
临床怎么用
- 对于近吻合口AVF狭窄,DEB血管成形术可作为改善12个月通畅率的治疗选择。
- 需结合患者具体情况和长期证据决定是否优先使用DEB而非PTA。
局限性
- 纳入研究数量有限(荟萃分析仅3项研究、141例患者),需进一步高质量数据确认。
- 部分研究为观察性设计,存在偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Owing to the lack of comparative evidence between the endovascular technologies for arteriovenous fistula (AVF) stenosis treatments, we sought to summarize the reported data comparing the effectiveness of different endovascular approaches for the treatment of AVF stenoses at the juxta-anastomotic site. METHODS: We performed a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases were searched from inception to June 12, 2018 for observational and randomized studies that had examined the effectiveness of AVF stenosis treatment using plain percutaneous balloon angioplasty (PTA), cutting balloon angioplasty, drug-eluting balloon (DEB) angioplasty, high-pressure balloon angioplasty, and stenting. Bias was assessed using the Newcastle-Ottawa scale for observational studies and the Cochrane Collaboration tool for randomized studies. Article screening, full-text review, assessment of bias, and data collection were conducted in duplicate, with a third reviewer to reconcile any discrepancies. We conducted a qualitative synthesis of the available evidence and a quantitative meta-analysis for the primary assisted patency outcome. The meta-analysis was conducted using Review Manager, version 5.3, using random effects models, with the I2 statistic used to assess heterogeneity. Statistical significance was set at P < .05. RESULTS: Our search yielded 3683 reports. Of these, three randomized trials and three observational studies were included. Three studies with 342 patients had described the effectiveness of high-pressure balloon angioplasty, conventional PTA, and stenting and had analyzed the data qualitatively. Three studies with 141 patients had investigated native AVF patency after DEB angioplasty and conventional PTA and were included in the meta-analysis. DEB angioplasty showed significantly greater primary assisted patency rates at 12 months after treatment compared with PTA (odds ratio, 3.66; 95% confidence interval, 1.32-10.14; I2 = 49%). No statistically significant differences were found in 6-month primary assisted patency among the treatment groups (odds ratio, 2.03; 95% confidence interval, 0.64-6.45; I2 = 50%). A total of 58 of 72 AVFs remained patent 6 months after DEB angioplasty compared with 45 of 69 at 6 months after PTA. At 12 months after treatment, 48 of 72 AVFs remained patent after DEB angioplasty compared with 23 of 69 AVFs after PTA. CONCLUSIONS: Our findings suggest DEB angioplasty is a more effective treatment option for AVF stenosis at the juxta-anastomotic site compared with PTA. Although DEB angioplasty might provide longer term patency than other endovascular treatments, further high-quality data are needed to confirm this finding.
引用
- Rokoszak V, Syed MH, Salata K, et al. A systematic review and meta-analysis of plain versus drug-eluting balloon angioplasty in the treatment of juxta-anastomotic hemodialysis arteriovenous fistula stenosis. J Vasc Surg. 2020. PMID: 32089200. doi:10.1016/j.jvs.2019.07.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。